Cynata Therapeutics Ltd has released a press release.
Further data supports potency of Cynata MSCs
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- FDA Clears Cynata IND for Phase 2 Trial in GvHD
- Notice of Allowance for Cynata Chinese Patent
- Cynata Receives Decision to Grant a Patent in Japan
- FUJIFILM Cellular Dynamics Executes Manufacturing Agreement
- Cynata Commences DFU Clinical Trial
Later from Cynata Therapeutics
- Pipeline Update Following Strategic Portfolio Review
- Grant Award to Fund Study of Cynata MSCs in Heart Disease
- Successful Completion of Planned DSMB Review of DFU Trial
- Notice of Allowance for Australia & Canada Cymerus Patents
- New Kidney Transplantation Clinical Trial for Cynata & LUMC
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics